JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
iShares Core International Aggregate Bond Fund
IAGG
$12.5B
| $280K | ﹤0.01% |
5,115
+144
| +3% | +$7.97K |
2018 Q4
5 quarters
|
|
3952
PennantPark Floating Rate Capital
PFLT
$673M
| $279K | ﹤0.01% |
57,361
+12,050
| +27% | +$126K |
2013 Q2
27 quarters
|
|
|
NPKI
3953
NPK International
NPKI
$1B
| $279K | ﹤0.01% |
310,486
+208,505
| +204% | +$781K |
2016 Q4
13 quarters
|
|
|
DCPH
3954
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $279K | ﹤0.01% |
6,789
-80,401
| -92% | -$4.46M |
2017 Q4
9 quarters
|
|
3955
Transmedics
TMDX
$2.88B
| $278K | ﹤0.01% |
23,051
+13,988
| +154% | +$234K |
2019 Q2
3 quarters
|
|
|
IBTX
3956
DELISTED
Independent Bank Group, Inc.
IBTX
| $278K | ﹤0.01% |
11,758
-47,880
| -80% | -$2.2M |
2017 Q4
9 quarters
|
|
3957
ANI Pharmaceuticals
ANIP
$1.67B
| $277K | ﹤0.01% |
6,801
-276
| -4% | -$14.7K |
2016 Q1
16 quarters
|
|
3958
South Plains Financial
SPFI
$805M
| $276K | ﹤0.01% |
17,832
+5,284
| +42% | +$101K |
2019 Q2
3 quarters
|
|
3959
PUT
Alcon
ALC
$31.1B
| $274K | ﹤0.01% |
5,400
+1,000
| +23% | +$57.5K |
2019 Q4
1 quarter
|
|
|
FPI
3960
Farmland Partners
FPI
$486M
| $273K | ﹤0.01% |
44,960
-4,058
| -8% | -$26K |
2016 Q1
16 quarters
|
|
|
EFC
3961
Ellington Financial
EFC
$1.48B
| $271K | ﹤0.01% |
47,423
-78,984
| -62% | -$1.23M |
2018 Q4
5 quarters
|
|
3962
Norwood Financial Corp
NWFL
$368M
| $271K | ﹤0.01% |
10,173
+2,286
| +29% | +$75.5K |
2017 Q4
9 quarters
|
|
3963
BCB Bancorp
BCBP
$260M
| $270K | ﹤0.01% |
25,405
+10,506
| +71% | +$129K |
2017 Q4
9 quarters
|
|
|
CGC
3964
PUT
Canopy Growth
CGC
$374M
| $270K | ﹤0.01% |
1,870
-11,670
| -86% | -$2.19M |
2019 Q4
1 quarter
|
|
3965
PUT
Ovintiv
OVV
$16.9B
| $270K | ﹤0.01% |
+100,000
| New | +$1.31M |
2020 Q1
0 quarters
|
|
|
ESXB
3966
DELISTED
Community Bankers Trust Corporation
ESXB
| $270K | ﹤0.01% |
55,820
+17,233
| +45% | +$137K |
2017 Q4
9 quarters
|
|
|
EEX
3967
DELISTED
Emerald Holding
EEX
| $269K | ﹤0.01% |
103,897
-99,139
| -49% | -$781K |
2017 Q2
11 quarters
|
|
|
SUP
3968
DELISTED
Superior Industries International
SUP
| $269K | ﹤0.01% |
224,016
-246,816
| -52% | -$651K |
2015 Q4
17 quarters
|
|
|
PWOD
3969
DELISTED
Penns Woods Bancorp
PWOD
| $268K | ﹤0.01% |
11,072
+2,166
| +24% | +$64.1K |
2016 Q4
13 quarters
|
|
|
ALOT
3970
DELISTED
AstroNova
ALOT
| $267K | ﹤0.01% |
34,370
-961
| -3% | -$11.1K |
2018 Q2
7 quarters
|
|
3971
Geospace Technologies
GEOS
$61.4M
| $267K | ﹤0.01% |
41,695
+35,820
| +610% | +$426K |
2015 Q3
18 quarters
|
|
|
EMWP
3972
PUT
DELISTED
Eros Media World PLC
EMWP
| $266K | ﹤0.01% |
8,070
-1,050
| -12% | -$57.7K |
2019 Q4
1 quarter
|
|
|
HEES
3973
DELISTED
H&E Equipment Services
HEES
| $265K | ﹤0.01% |
18,009
-1,177,100
| -98% | -$28.5M |
2015 Q4
17 quarters
|
|
3974
LifeVantage
LFVN
$75.9M
| $265K | ﹤0.01% |
25,775
+21,265
| +472% | +$291K |
2016 Q4
13 quarters
|
|
3975
Riverview Bancorp
RVSB
$120M
| $265K | ﹤0.01% |
53,037
-32,296
| -38% | -$216K |
2016 Q3
14 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.